CYREN LTD (CYRN) Stock Fundamental Analysis

NASDAQ:CYRN • IL0010832371

0.2182 USD
-0.06 (-20.65%)
At close: Mar 2, 2023
0.204 USD
-0.01 (-6.51%)
After Hours: 3/2/2023, 8:00:01 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to CYRN. CYRN was compared to 276 industry peers in the Software industry. Both the profitability and financial health of CYRN have multiple concerns. CYRN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • CYRN had negative earnings in the past year.
  • CYRN had a negative operating cash flow in the past year.
CYRN Yearly Net Income VS EBIT VS OCF VS FCFCYRN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 0 -5M -10M -15M -20M

1.2 Ratios

  • CYRN has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CYRN Yearly ROA, ROE, ROICCYRN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 -50 -100 -150

1.3 Margins

  • With a Gross Margin value of 44.77%, CYRN is not doing good in the industry: 70.90% of the companies in the same industry are doing better.
  • In the last couple of years the Gross Margin of CYRN has declined.
  • CYRN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 44.77%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5%
GM growth 5Y-5.47%
CYRN Yearly Profit, Operating, Gross MarginsCYRN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • CYRN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • CYRN has less shares outstanding than it did 1 year ago.
  • Compared to 1 year ago, CYRN has an improved debt to assets ratio.
CYRN Yearly Shares OutstandingCYRN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 20M 40M 60M
CYRN Yearly Total Debt VS Total AssetsCYRN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 20M 40M 60M

2.2 Solvency

  • Based on the Altman-Z score of -13.46, we must say that CYRN is in the distress zone and has some risk of bankruptcy.
  • CYRN has a Altman-Z score of -13.46. This is amonst the worse of the industry: CYRN underperforms 90.64% of its industry peers.
  • A Debt/Equity ratio of 2.30 is on the high side and indicates that CYRN has dependencies on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 2.30, CYRN is doing worse than 81.94% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 2.3
Debt/FCF N/A
Altman-Z -13.46
ROIC/WACCN/A
WACC3.12%
CYRN Yearly LT Debt VS Equity VS FCFCYRN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 0 20M 40M

2.3 Liquidity

  • A Current Ratio of 1.29 indicates that CYRN should not have too much problems paying its short term obligations.
  • CYRN has a worse Current ratio (1.29) than 65.22% of its industry peers.
  • CYRN has a Quick Ratio of 1.29. This is a normal value and indicates that CYRN is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of CYRN (1.29) is worse than 64.21% of its industry peers.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 1.29
CYRN Yearly Current Assets VS Current LiabilitesCYRN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 5M 10M 15M 20M 25M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • CYRN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 23.04%, which is quite impressive.
  • The Revenue for CYRN has decreased by -13.53% in the past year. This is quite bad
  • CYRN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.13% yearly.
EPS 1Y (TTM)23.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%41.67%
Revenue 1Y (TTM)-13.53%
Revenue growth 3Y-4.58%
Revenue growth 5Y0.13%
Sales Q2Q%3.88%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CYRN Yearly Revenue VS EstimatesCYRN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 10M 20M 30M
CYRN Yearly EPS VS EstimatesCYRN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 -2 -4 -6

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • CYRN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CYRN Price Earnings VS Forward Price EarningsCYRN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CYRN Per share dataCYRN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • CYRN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

CYREN LTD

NASDAQ:CYRN (3/2/2023, 8:00:01 PM)

After market: 0.204 -0.01 (-6.51%)

0.2182

-0.06 (-20.65%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-21
Earnings (Next)05-15
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners46.3%
Ins Owner Change0%
Market Cap1.75M
Revenue(TTM)24.66M
Net Income(TTM)-32.48M
Analysts82.86
Price Target1.53 (601.19%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.07
P/FCF N/A
P/OCF N/A
P/B 0.46
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-3.54
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.59
FCFYN/A
OCF(TTM)-1.57
OCFYN/A
SpS3.08
BVpS0.47
TBVpS-0.56
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 44.77%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5%
GM growth 5Y-5.47%
F-Score3
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 2.3
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 5.66%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.29
Quick Ratio 1.29
Altman-Z -13.46
F-Score3
WACC3.12%
ROIC/WACCN/A
Cap/Depr(3y)23.38%
Cap/Depr(5y)32.05%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)23.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%41.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-13.53%
Revenue growth 3Y-4.58%
Revenue growth 5Y0.13%
Sales Q2Q%3.88%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-27.62%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-7.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-24.44%
OCF growth 3YN/A
OCF growth 5YN/A

CYREN LTD / CYRN FAQ

What is the fundamental rating for CYRN stock?

ChartMill assigns a fundamental rating of 2 / 10 to CYRN.


Can you provide the valuation status for CYREN LTD?

ChartMill assigns a valuation rating of 3 / 10 to CYREN LTD (CYRN). This can be considered as Overvalued.


How profitable is CYREN LTD (CYRN) stock?

CYREN LTD (CYRN) has a profitability rating of 1 / 10.


How financially healthy is CYREN LTD?

The financial health rating of CYREN LTD (CYRN) is 1 / 10.